Carlisle Companies

CSLNYSEUSD

THESIS ALERT

Email me when the CSL thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$397.62
+$2.39 (+0.60%)Today 1M +23.37%
After hours$397.620.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$395.23
Prior regular-session close from the quote source.
$388.44–$399.00
Regular-session low and high so far today.
390.4K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$293.43–$432.91
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own CSL if Carlisle turns defensive, recurring demand for building maintenance (especially commercial re-roofing), disciplined operational improvements (COS + factory automation) and acquisitive, capital-returning deployment of strong free cash flow into share buybacks and bolt-ons into durable.

CSL price history

Latest price$397.62Today+$2.39 (+0.60%)
CSL +24.16%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • A large, recurring re‑roofing market provides a stable baseline demand that cushions Carlisle's revenue during new construction downturns, making revenue and cash generation relatively resilient.StrengtheningMateriality: High

    MD&A states ~70% of commercial roofing is re‑roofing and that re‑roofing helped stabilize CCM in 2025. If true, Carlisle can deliver predictable cash and justify conservative multiples; if false, revenues become highly cyclical and margins face greater downside on volume drops.

    Watch: A prolonged macro slump that materially reduces commercial maintenance budgets or owner willingness to re‑roof (e.g., sustained fall in non‑residential construction investment).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    MD&A states ~70% of commercial roofing is re‑roofing and that re‑roofing helped stabilize CCM in 2025.

    Open source ↗
  • Carlisle Operating System (COS), factory automation and targeted R&D will offset absorption and input‑cost pressure enough to keep operating margins broadly resilient over the cycle.HoldingMateriality: High

    Management emphasizes COS, automation and increased R&D investment as Vision 2030 pillars in MD&A. Margins determine free cash and the ability to fund buybacks/M&A; if COS cannot offset lower volumes or rising costs, cash returns and valuation are threatened.

    Watch: MD&A notes gross margin decline due to higher unit costs and lower absorption—this exact mechanism can persist and continue compressing margins.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Management emphasizes COS, automation and increased R&D investment as Vision 2030 pillars in MD&A.

    Open source ↗
  • Sustained >$1B operating cash flow allows Carlisle to fund bolt‑on acquisitions and share repurchases that meaningfully increase EPS even if organic top‑line growth is modest.HoldingMateriality: Medium

    Operating cash flow > $1B in 2025 (reported as $1,101.8M) and management commentary that significant portion of cash was used for share repurchases. If free cash stays strong and management keeps returning capital to shareholders with disciplined M&A, EPS can compound and justify the current multiple; if cash falls or acquisitions are not accretive, EPS gains reverse.

    Watch: Acquisitions that increase amortization and SG&A (MD&A notes $15.8M amortization and $16.1M higher wages/benefits from acquisitions), which could mute EPS accretion.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow > $1B in 2025 (reported as $1,101.8M) and management commentary that significant portion of cash was used.

    Open source ↗
  • Consistent >$1B operating cash flow and a cash balance above historical levels give Carlisle balance‑sheet optionality to invest, buy back shares, and withstand cyclicality without forced distress.StrengtheningMateriality: Medium

    Operating_cash_flow: $1,101.8M in 2025, with prior years similarly >$1B (2023: $1,201.3M. Optionality reduces financing risk and supports aggressive buybacks and bolt‑ons; loss of cash flow removes that flexibility and raises refinancing or dilution risk.

    Watch: Material acquisitions funded with debt could raise leverage and interest expense (MD&A notes issuance of 2035 and 2040 notes and higher interest expense).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating_cash_flow: $1,101.8M in 2025, with prior years similarly >$1B (2023: $1,201.3M.

    Open source ↗
  • Carlisle's acquisition strategy creates goodwill and intangible assets that pose a real impairment risk if organic growth or margin assumptions used in valuations fail, which would hit net income and equity.HoldingMateriality: Medium

    Business text details material goodwill allocation ($1,538.9M as of Dec 31, 2025) and describes the annual impairment test and judgmental assumptions. An impairment would be a one‑time earnings hit, reduce book equity and could signal weaker-than-assumed demand or failed integrations—both would pressure the stock multiple.

    Watch: Management performed a qualitative impairment test as of Nov 1, 2025 and concluded it was not more likely than not that reporting units were impaired.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Business text details material goodwill allocation ($1,538.9M as of Dec 31, 2025) and describes the annual impairment test and judgmental.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

A large, recurring re‑roofing market provides a stable baseline demand that cushions Carlisle's revenue during new construction downturns, making revenue and cash generation relatively resilient. If true, Carlisle can deliver predictable cash and justify conservative multiples; if false, revenues become highly cyclical and margins face greater downside on volume drops.

Carlisle Operating System (COS), factory automation and targeted R&D will offset absorption and input‑cost pressure enough to keep operating margins broadly resilient over the cycle. Margins determine free cash and the ability to fund buybacks/M&A; if COS cannot offset lower volumes or rising costs, cash returns and valuation are threatened.

Sustained >$1B operating cash flow allows Carlisle to fund bolt‑on acquisitions and share repurchases that meaningfully increase EPS even if organic top‑line growth is modest. If free cash stays strong and management keeps returning capital to shareholders with disciplined M&A, EPS can compound and justify the current multiple; if cash falls or acquisitions are not accretive, EPS gains reverse.

Consistent >$1B operating cash flow and a cash balance above historical levels give Carlisle balance‑sheet optionality to invest, buy back shares, and withstand cyclicality without forced distress. Optionality reduces financing risk and supports aggressive buybacks and bolt‑ons; loss of cash flow removes that flexibility and raises refinancing or dilution risk.

Carlisle's acquisition strategy creates goodwill and intangible assets that pose a real impairment risk if organic growth or margin assumptions used in valuations fail, which would hit net income and equity. An impairment would be a one‑time earnings hit, reduce book equity and could signal weaker-than-assumed demand or failed integrations—both would pressure the stock multiple.

All standing thesis claims
Original report summary

Carlisle turns defensive, recurring demand for building maintenance (especially commercial re-roofing), disciplined operational improvements (COS + factory automation) and acquisitive, capital-returning deployment of strong free cash flow into share buybacks and bolt-ons into durable.

Evidence assessed Nov 6, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Carlisle Companies

Where the evidence on Carlisle Companies stands: Holding on the latest evidence (Nov 6, 2026). Of its 5 thesis points, 2 strengthening and 3 holding.

Bull case: what the evidence supports

  • A large, recurring re‑roofing market provides a stable baseline demand that cushions Carlisle's revenue during new construction downturns, making revenue and cash generation relatively resilient.

    sec.gov ↗

  • Carlisle Operating System (COS), factory automation and targeted R&D will offset absorption and input‑cost pressure enough to keep operating margins broadly resilient over the cycle.

    sec.gov ↗

  • Sustained >$1B operating cash flow allows Carlisle to fund bolt‑on acquisitions and share repurchases that meaningfully increase EPS even if organic top‑line growth is modest.

    sec.gov ↗

  • Consistent >$1B operating cash flow and a cash balance above historical levels give Carlisle balance‑sheet optionality to invest, buy back shares, and withstand cyclicality without forced distress.

    sec.gov ↗

  • Carlisle's acquisition strategy creates goodwill and intangible assets that pose a real impairment risk if organic growth or margin assumptions used in valuations fail, which would hit net income and equity.

    sec.gov ↗

Bear case: what would count against it

  • A prolonged macro slump that materially reduces commercial maintenance budgets or owner willingness to re‑roof (e.g., sustained fall in non‑residential construction investment).

    sec.gov ↗

  • MD&A notes gross margin decline due to higher unit costs and lower absorption—this exact mechanism can persist and continue compressing margins.

    sec.gov ↗

  • Acquisitions that increase amortization and SG&A (MD&A notes $15.8M amortization and $16.1M higher wages/benefits from acquisitions), which could mute EPS accretion.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Carlisle Companies

Loading the break-condition record for Carlisle Companies.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Carlisle Companies filed an SEC 8-K on 2026-10-28: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    Carlisle Companies filed an SEC 8-K on 2026-09-10: Director or principal officer change. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Carlisle Companies filed an SEC 8-K on 2026-07-29: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A prolonged macro slump that materially reduces commercial maintenance budgets or owner willingness to re‑roof (e.g., sustained fall in non‑residential construction investment).
  • MD&A notes gross margin decline due to higher unit costs and lower absorption—this exact mechanism can persist and continue compressing margins.
  • Acquisitions that increase amortization and SG&A (MD&A notes $15.8M amortization and $16.1M higher wages/benefits from acquisitions), which could mute EPS accretion.
  • Material acquisitions funded with debt could raise leverage and interest expense (MD&A notes issuance of 2035 and 2040 notes and higher interest expense).
  • Management performed a qualitative impairment test as of Nov 1, 2025 and concluded it was not more likely than not that reporting units were impaired.

CSL news

Loading headlines…

Financial statements

CSL income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

CSL: quick answers

Have members of Congress traded CSL?
32 trades in CSL have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed CSL trade
Which well-known investors own CSL?
1 of the 37 well-known funds tracked here reported CSL shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios

CSL in well-known investors’ portfolios

1 of 37 funds reported CSL shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Ray DalioBridgewater Associates0.04%$10.9M+27.3%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.